Objective. To search for a relationship between serum anti-b2 glycoprotein I (anti-b2GPI ) antibodies and the occurrence of ischaemic complications in giant cell arteritis (GCA), since the latter do not correlate with anti-cardiolipin antibodies (ACL), which are frequently observed in GCA.
G cell arteritis (GCA) predominantly affects from APS patients with thrombosis [3, 4] . In our experience, such IgG anti-b2GPI antibodies were signifimedium-and large-sized arteries. The initial lesions are marked by inflammatory infiltrates of the vessel cantly associated with b2GPI-dependent IgG ACL in APS (82 cases, P = 0.006, Spearman test). In addition, wall. Activated T lymphocytes infiltrate temporal arteries, supporting the hypothesis that the pathogenesis of antibodies directed against b2GPI alone, in its native form (detected using non-irradiated plates), were found GCA involves a T-cell response against an unknown arterial component [1] . The course of the disease is in APS patients in the absence of other detectable antiphospholipid antibodies [9] . In GCA, moderate serum characterized by the occurrence of arterial thrombosis which is not foreseeable, and leads to blindness, levels of ACL, mainly of the IgG class, are frequently detected [10] [11] [12] [13] [14] . The correlation of ACL with the myocardial or limb ischaemia, or stroke. These complications affect only certain patients and several studoccurrence of ischaemic complications is a matter of controversy [10, 11] . Our previous study failed to ies failed to define a predictive biological factor, except for thrombocytosis in a study [2] . Anti-phospholipid demonstrate any correlation [14] . There are virtually no data on anti-b2GPI antibodies in GCA, except for antibodies are known to be associated with vascular thrombosis in diseases such as systemic lupus erytha study which included 19 treated and untreated patients and reported ACL and anti-b2GPI antibodies ematosus, and define the biological criteria of the antiphospholipid syndrome (APS). Anti-cardiolipin antiin eight and two cases, respectively [15] . We therefore studied anti-b2GPI antibodies, before treatment, in bodies (ACL) were first described, but antibodies directed against b2 glycoprotein I ( b2GPI ), which is sera from 45 patients with proven GCA. the cofactor for the main group of anti-phospholipid METHODS antibodies ( lupus anticoagulant and ACL), appear to Patients be more significant in terms of the occurrence of Anti-b2GPI antibodies and ACL were searched for thrombosis [3] [4] [5] [6] . The dependence of ACL on b2GPI prior to therapy in the serum from 45 informed and seems to be critical in their pathogenesis, b2GPI-consenting patients (16 males, 29 females, mean age independent ACL being observed in the absence of 74.9 ± 7.3 yr, range 57-93), with characteristic histothrombosis in various conditions, such as certain infeclogical features of GCA on temporal biopsies. tions or drug-induced manifestations [7] . In addition, Revealing symptoms were cranial symptoms without the coating of b2GPI alone on irradiated plates allows polymyalgia rheumatica (28 cases), both cranial sympthe detection of antibodies directed against an epitope toms and polymyalgia rheumatica (12 cases), isolated of b2GPI exposed following its interaction with oxidpolymyalgia rheumatica (one case) and systemic sympized plastic surface [8] . These anti-b2GPI antibodies, toms with fever (four cases). Ischaemic complications mainly of the IgG class, were detected in association were diagnosed in 15 patients (33.3%), at presentation with other IgG anti-phospholipid antibodies in sera in all but three cases. In patients 3, 8 and 15, they occurred 5, 2 or 10 days after diagnosis, respectively, background subtraction) were taken into account. after diagnosis in patient 10), upper limb ischaemia Antibody levels were expressed in arbitrary units by (cases 2 and 5) and an extensive vertebrobasilar stroke reference to positive and negative sera used as internal (patient 3) ( Table I ) . Ocular involvements were standards in every plate. The cut-off value for positive revealed, on the one hand, by permanent visual loss, levels (28 IgG units and 10 IgM units) was determined related to an anterior ischaemic optic neuropathy from the study of 82 sera with known anti-(AION ) diagnosed by fundoscopy and retinal angiogphospholipid antibodies (from primary APS and lupus raphy findings in six cases (nos 1, 7, 8, 9, 11 and 12) erythematosus patients) and 107 sera from healthy or to an ischaemic retrobulbar optic neuritis (IRON ) subjects, according to Griner et al. [17] , with a specifiwith normal fundoscopy in two patients (nos 10 and city of 84% and a sensitivity of 56%. 15) and, on the other hand, by transient visual loss in ACL were also searched for by ELISA [18], followtwo cases (nos 13 and 14) and blurred vision associated ing the same procedure as above, except for microwith diplopia (case 6).
titration plates (Immunosorb, Nunc) coated with cardiolipin purified from bovine heart (Sigma) and Antibody detection saturated with 1% BSA in PBS. The same solution was Anti-b2GPI antibodies were characterized by also used for serum dilutions (1/100). ACL levels were enzyme-linked immunosorbent assay ( ELISA) [16 ] expressed in IgM and IgG units calculated using sera with purified human b2GPI (Stago, Asnière, France) calibrated with Harris' standards [19] included in every controlled by polyacrylamide gel electrophoresis. plate, with positive levels Á 20 U. Polystyrene irradiated microplates (Maxisorp, Nunc, Roskilde, Denmark) were coated for 18 h at 4°C with RESULTS 200 ng/well of b2GPI diluted in phosphate-buffered Anti-b2GPI antibodies were not detected at positive saline solution (PBS; 50 ml/well ). After saturation with levels in any untreated patients with GCA, either of PBS-0.1% Tween 20 (Sigma, St Louis, MO, USA) the IgG (mean level 3 ± 5, range 0-26 U ) or IgM containing 1% bovine serum albumin (BSA; Diamed, (mean level 3 ± 2, range 0-10 U ) classes. In contrast, Cressier/Morat, Switzerland ), sera diluted 1/100 in the confirming previous results [14], ACL were found to latter solution were incubated for 1 h at 37°C in be positive in 51% (23/45) of sera (mean level 52 ± 29, triplicate in coated and uncoated (blank) wells. After range 21-110 U ). These ACL belonged mainly to the six washes with PBS-0.05% Tween 20, biotin-coupled IgG class, except for a patient without ischaemic monospecific anti-human IgG (c chain specific) or IgM complication, who only had a low level of IgM ACL ( m chain specific) antibodies (Amersham, Les Ulis, (34 U ). ACL did not correlate significantly with the France) were added at a 1/1000 dilution and incubated occurrence of ischaemia (P = 0.83, x2 test; P = 0.93, for 1 h. After washing, the streptavidin-peroxidase Mann-Whitney U-test). The mean platelet level was complex (Amersham) diluted 1/1000 in PBS was incubated for 30 min at 37°C. The reaction was revealed 438.5 ± 133 × 109/l (range 216-913 × 109/l ) without be merely secondary and induced by local inflamma-13. Chakravarty K, Pountain G, Merry P, Byron M, tion. This hypothesis is supported by the dramatic
